FibroBiologics Management
Management criteria checks 3/4
FibroBiologics' CEO is Pete O’Heeron, appointed in Apr 2021, has a tenure of 4.08 years. total yearly compensation is $1.81M, comprised of 33.2% salary and 66.8% bonuses, including company stock and options. directly owns 15.44% of the company’s shares, worth $5.62M. The average tenure of the management team and the board of directors is 2.5 years and 4.1 years respectively.
Key information
Pete O’Heeron
Chief executive officer
US$1.8m
Total compensation
| CEO salary percentage | 33.2% |
| CEO tenure | 4.1yrs |
| CEO ownership | 15.4% |
| Management average tenure | 2.5yrs |
| Board average tenure | 4.1yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | US$2m | US$600k | -US$11m |
| Sep 30 2024 | n/a | n/a | -US$18m |
| Jun 30 2024 | n/a | n/a | -US$19m |
| Mar 31 2024 | n/a | n/a | -US$23m |
| Dec 31 2023 | US$4m | US$600k | -US$19m |
| Sep 30 2023 | n/a | n/a | -US$11m |
| Jun 30 2023 | n/a | n/a | -US$10m |
| Mar 31 2023 | n/a | n/a | -US$9m |
| Dec 31 2022 | US$922k | US$600k | -US$5m |
Compensation vs Market: Pete's total compensation ($USD1.81M) is above average for companies of similar size in the US market ($USD664.94K).
Compensation vs Earnings: Pete's compensation has been consistent with company performance over the past year.
CEO
Pete O’Heeron (60 yo)
4.1yrs
Tenure
US$1,805,199
Compensation
Mr. Peter O'Heeron, MSHA, also known as Pete, is the Founder, Chairperson & Chief Executive Officer at FibroBiologics, Inc. (Formerly, FibroBiologics LLC) since April 2021. Mr. O’Heeron is also the founder...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 4.1yrs | US$1.81m | 15.44% $ 5.6m | |
| Interim CFO & Director | less than a year | US$688.53k | 0.020% $ 7.1k | |
| Chief Scientific Officer | 3.8yrs | US$853.65k | 0.029% $ 10.7k | |
| General Counsel | 1.2yrs | US$2.75m | 0% $ 0 |
2.5yrs
Average Tenure
56yo
Average Age
Experienced Management: FBLG's management team is considered experienced (2.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 4.1yrs | US$1.81m | 15.44% $ 5.6m | |
| Interim CFO & Director | 4.1yrs | US$688.53k | 0.020% $ 7.1k | |
| Independent Director | 4.1yrs | US$57.17k | 0.24% $ 88.7k | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Independent Director | 4.1yrs | US$57.04k | 0.020% $ 7.1k | |
| Independent Director | 4.1yrs | US$54.80k | 0.020% $ 7.1k | |
| Independent Director | 3.8yrs | US$65.17k | 0.020% $ 7.1k | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Scientific Advisory Board Member | no data | no data | no data | |
| Scientific Advisory Board Member | no data | no data | no data |
4.1yrs
Average Tenure
58yo
Average Age
Experienced Board: FBLG's board of directors are considered experienced (4.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/06 02:32 |
| End of Day Share Price | 2025/05/06 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
FibroBiologics, Inc. is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Kolbert | D. Boral Capital LLC. |
| Matthew Caufield | H.C. Wainwright & Co. |
| Jason McCarthy | Maxim Group |